Boxer Capital of the Tavistock Group

Boxer Capital, a venture capital firm of the Tavistock Group, focuses on identifying and investing in new therapeutics that improve patient care and outcomes. Their strategy involves investing across the entire drug development lifecycle, from early-stage preclinical discovery to late-stage clinical and commercial-stage companies, primarily within the biotechnology and life sciences sectors, with a strong emphasis on targeted oncology.